Study guide
13.2 Epidural & Combined Spinal-Epidural (CSE) Techniques & PDPH
NBCRNA CRNA Certified Registered Nurse Anesthetist NCE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Cardiovascular, Respiratory & CNS Physiology & Pathophysiology
1.1 Cardiovascular Physiology, Hemodynamics & Ischemic Heart Disease 1.2 Respiratory Physiology, Lung Volumes & Chronic Pulmonary Pathophysiology 1.3 Central & Autonomic Nervous System Physiology & Neurological Disorders
2 Chapter 2: Hepatorenal, Endocrine & Hematologic/Immune Systems
2.1 Renal Physiology, Glomerular Filtration & Acid-Base Balance 2.2 Hepatic Physiology, Drug Clearance & Gastrointestinal Considerations 2.3 Endocrine Disorders, Hematology, Coagulation & Immune Mechanisms
3 Chapter 3: Anesthetic Pharmacology: Inhalation Agents, Intravenous Anesthetics & Sedatives
3.1 Inhalation Anesthetics: Uptake, Distribution, Blood/Gas Solubility & MAC 3.2 Intravenous Hypnotics: Propofol, Etomidate, Ketamine & Barbiturates 3.3 Opioid Agonists/Antagonists, Benzodiazepines & Reversal Pharmacology
4 Chapter 4: Anesthetic Pharmacology: Neuromuscular Blockers, Local Anesthetics & Physics
4.1 Neuromuscular Blocking Agents & Reversal: Anticholinesterases vs Sugammadex 4.2 Local Anesthetics: Mechanism, Potency, Toxicity (LAST) & Vasoconstrictors 4.3 Applied Physics, Gas Laws, Fluid Dynamics & Anesthesia Mathematics
5 Chapter 5: Anesthesia Delivery Systems & Gas Supplies
5.1 Medical Gas Supply Systems, Cylinders, Regulators & Safety Index Systems (PISS/DISS) 5.2 Anesthesia Machine High, Intermediate & Low Pressure Systems & Failsafe Mechanisms 5.3 Vaporizer Technology: Variable-Bypass vs Desflurane Vaporizers & Machine Checkout
6 Chapter 6: Breathing Circuits, CO2 Absorption & Ventilators
6.1 Breathing Circuits: Circle System, Mapleson Classifications & Dead Space 6.2 Carbon Dioxide Absorption: Soda Lime Chemistry, Desiccation, Carbon Monoxide & Compound A 6.3 Anesthesia Ventilators, Pressure/Volume Modes, APL Valves & Waste Gas Scavenging
7 Chapter 7: Airway Equipment & Advanced Airway Instrumentation
7.1 Face Masks, Supraglottic Airways (LMA Types) & Endotracheal Tubes 7.2 Direct Laryngoscopy (Mac/Miller) & Video Laryngoscopy 7.3 Fiberoptic Intubation, Bronchial Blockers, Double-Lumen Tubes & Surgical Airways
8 Chapter 8: Patient Monitoring, Hemodynamics & Electrosurgical Safety
8.1 Noninvasive Monitoring: Pulse Oximetry, Capnography Waveforms & Temperature 8.2 Invasive Hemodynamics: Arterial Lines, CVP & Pulmonary Artery Catheters 8.3 Neuromuscular Monitoring (TOF/PTC), Depth of Anesthesia (EEG/BIS) & Electrical Safety
9 Chapter 9: Preoperative Assessment, Risk Stratification & Preparation
9.1 Preoperative History, Physical Examination & ASA Physical Status Classification 9.2 Cardiac & Pulmonary Risk Stratification, Diagnostic Testing & Optimization 9.3 Preoperative Fasting Guidelines, Aspiration Prophylaxis & Premedication
10 Chapter 10: Fluid Management, Blood Component Therapy & Coagulation Monitoring
10.1 Crystalloids vs Colloids, Maintenance & Deficit Calculations 10.2 Blood Component Therapy, Transfusion Triggers & Massive Transfusion Protocols 10.3 Point-of-Care Coagulation: TEG, ROTEM & Perioperative Coagulopathies
11 Chapter 11: Airway Management Strategies & Difficult Airway Algorithms
11.1 Difficult Airway Assessment: Mallampati, Cormack-Lehane & Airway Predictors 11.2 ASA Difficult Airway Algorithm: Anticipated vs Unanticipated Difficult Airway 11.3 "Cannot Intubate, Cannot Oxygenate" (CICO) & Emergency Front-of-Neck Access (eFONA)
12 Chapter 12: General Anesthesia: Induction, Maintenance, Emergence & TIVA
12.1 Rapid Sequence Induction (RSI), Cricoid Pressure & Intubation Protocols 12.2 Balanced Anesthesia vs Total Intravenous Anesthesia (TIVA) Principles 12.3 Emergence, Extubation Criteria, Deep vs Awake Extubation & Laryngospasm
13 Chapter 13: Regional Anesthesia: Neuraxial Blocks
13.1 Spinal Anesthesia: Anatomy, Physiology, High Spinal & Complications 13.2 Epidural & Combined Spinal-Epidural (CSE) Techniques & PDPH 13.3 Neuraxial Anticoagulation Guidelines (ASRA) & Epidural Hematoma
14 Chapter 14: Regional Anesthesia: Peripheral Nerve Blocks & Ultrasound Guidance
14.1 Upper Extremity Peripheral Nerve Blocks: Interscalene, Supraclavicular, Axillary 14.2 Lower Extremity & Truncal Blocks: Femoral, Sciatic, TAP & ESP Blocks 14.3 Ultrasound Physics, Needle Visualization & LAST Rescue Protocols
15 Chapter 15: Perioperative Safety, Positioning, PACU, Ethics & Professional Practice
15.1 Surgical Positioning Complications: Nerve Injuries & Physiologic Changes 15.2 PACU Discharge Criteria, PONV Management, Hypoxemia & Emergence Delirium 15.3 Malignant Hyperthermia Protocol & Operating Room Crisis Management 15.4 CRNA Ethics, Informed Consent, Scope of Practice & Wellness Initiatives
16 Chapter 16: Obstetric & Gynecologic Anesthesia
16.1 Maternal Physiology & Pharmacokinetics Across Trimesters 16.2 Labor Analgesia & Anesthesia for Cesarean Delivery 16.3 Obstetric Emergencies: Preeclampsia, Hemorrhage & Amniotic Fluid Embolism 16.4 Nonobstetric Surgery in the Pregnant Patient
17 Chapter 17: Pediatric Anesthesia
17.1 Pediatric Anatomy, Physiology, Airway & Developmental Pharmacology 17.2 Pediatric Induction, Maintenance, Fluids & Emergence Agitation 17.3 Pediatric Respiratory Emergencies: Croup, Epiglottitis & Laryngospasm
18 Chapter 18: Geriatric, Bariatric & Ambulatory Anesthesia
18.1 Geriatric Physiology, Pharmacodynamics & Postoperative Delirium/POCD 18.2 Bariatric Anesthesia: Obesity Hypoventilation, OSA & Dosing Adjustments 18.3 Ambulatory Surgery Selection Criteria & ERAS Protocols
19 Chapter 19: Cardiac, Vascular & Thoracic Anesthesia
19.1 Valvular Heart Disease, CAD & Cardiopulmonary Bypass Management 19.2 Vascular Anesthesia: Carotid Endarterectomy & Aortic Cross-Clamping 19.3 Thoracic Anesthesia: One-Lung Ventilation & Hypoxic Pulmonary Vasoconstriction
20 Chapter 20: Neurosurgical, Intra-Abdominal, Extrathoracic, Head/Neck & Trauma Anesthesia
20.1 Neurosurgical Anesthesia: ICP Dynamics, Craniotomy & Venous Air Embolism 20.2 Intra-Abdominal, Laparoscopy & Endocrine Tumor Anesthesia (Pheochromocytoma, Carcinoid) 20.3 ENT/Shared Airway, Extrathoracic Procedures & Trauma/Burn Resuscitation
21 Chapter 21: Neurologic, Gastrointestinal & Substance-Related Pathophysiology and Pharmacology
21.1 Neurodegenerative & Demyelinating Disease and Antiparkinsonian Pharmacology 21.2 Gastrointestinal & Exocrine Pancreatic Disorders: Esophageal, Gastric, Pancreatitis & Malabsorption 21.3 Cannabinoids, Herbal Remedies & Dietary Supplements
22 Chapter 22: Imaging Safety, Patient Warming & Infusion Technology
22.1 Fluoroscopy, Radiography & Radiation Safety in Anesthetizing Locations 22.2 Patient Warming Equipment & Rapid Infusion Devices
23 Chapter 23: Pain Medicine: Theory, Chronic Pain & Interventional Procedures
23.1 Pain Theory: Nociception, Sensitization & Chronic Pain Pathophysiology 23.2 Chronic Pain Management, Medication-Assisted Therapy & the Opioid-Tolerant Patient 23.3 Interventional Pain Procedures & Anesthesia for Pain Management Cases
24 Chapter 24: Professional Practice: Research Ethics, Error Disclosure & Provider Infection Control
24.1 Research Ethics, IRB Oversight & Protection of Human Subjects 24.2 Disclosure of Errors and Injuries, Adverse Event Reporting & Just Culture 24.3 Provider Infection Control: PPE, Air Handling & Occupational Exposure
25 Chapter 25: Neurosurgical Subspecialty Procedures
25.1 Cerebral Aneurysm Clipping, AVM Resection & Subarachnoid Hemorrhage 25.2 Transsphenoidal Hypophysectomy & Pituitary Surgery 25.3 Stereotactic Procedures, Deep Brain Stimulation & Awake Craniotomy 25.4 CSF Diversion, Burr Holes, Ventriculoperitoneal Shunts & Decompressive Craniectomy
26 Chapter 26: Head, Neck, Nasal, Dental & Ophthalmic Anesthesia
26.1 Nasal & Sinus Surgery, Nasotracheal Intubation & Craniofacial Procedures 26.2 Dental, Orthodontic, Oral-Maxillofacial & Ophthalmic Anesthesia 26.3 Neck Tumors, Radical Neck Dissection, Lymph Node Biopsy & Thyroid/Parathyroid Surgery
27 Chapter 27: Orthopedic & Extremity Anesthesia
27.1 Total Joint Arthroplasty, Bone Cement Implantation Syndrome & Tourniquet Physiology 27.2 Closed Reduction, Hand and Foot Procedures & Intravenous Regional (Bier) Block
28 Chapter 28: Non-Operating-Room Anesthesia: Interventional, Imaging & Radiation Therapy
28.1 Interventional and Neurointerventional Radiology Anesthesia 28.2 Radiation Therapy, Diagnostic Imaging & MRI-Suite Anesthesia
29 Chapter 29: Special Populations: Substance Use Disorder, Immunocompromised & Oncology Patients
29.1 Acute Intoxication, Withdrawal Syndromes & Perioperative Complications 29.2 Anesthesia for the Immunocompromised & Oncology Patient
13.2 Epidural & Combined Spinal-Epidural (CSE) Techniques & PDPH
Key Takeaways Explain This Topic AI
The epidural space is bounded anteriorly by the posterior longitudinal ligament, posteriorly by the ligamentum flavum and laminae, and laterally by the pedicles and intervertebral foramina; it contains adipose tissue, lymphatics, and the valveless Batson's internal vertebral venous plexus.
Batson's venous plexus engorges during pregnancy, morbid obesity, and increased intra-abdominal pressure, compressing the epidural space volume and dramatically increasing the risk of accidental intravascular catheter cannulation.
The standard epidural test dose (3 mL of 1.5% lidocaine with 1:200,000 epinephrine [15 mcg epi]) detects intravascular entry via a heart rate increase ≥20-30 bpm or SBP rise ≥15 mmHg within 30-60 seconds, and detects intrathecal entry via rapid (2-3 min) sensory/motor blockade.
Post-Dural Puncture Headache (PDPH) results from persistent transdural CSF leakage exceeding production (~0.35-0.5 mL/min), causing caudal brain sag, traction on pain-sensitive meninges/cranial nerves (especially CN VI abducens palsy), and compensatory Monro-Kellie cerebral vasodilation.
Epidural Blood Patch (EBP) using 15-20 mL of autologous blood placed at or one space below the dural puncture level is the gold standard definitive therapy for PDPH, achieving an 85-90% initial success rate.
Last updated: August 2026
13.2 Epidural & Combined Spinal-Epidural (CSE) Techniques & PDPH
Epidural anesthesia involves administering local anesthetics and adjuvants into the potential space surrounding the spinal dural sac. Combined spinal-epidural (CSE) techniques blend the rapid, reliable onset of subarachnoid anesthesia with the flexibility and prolonged duration of an indwelling epidural catheter. However, breeching the dural architecture introduces the risk of Post-Dural Puncture Headache (PDPH). Masterful understanding of epidural space boundaries, Batson's plexus dynamics, test dose pharmacology, and blood patching protocols is critical for NBCRNA NCE certification.
1. Epidural Space Anatomy & Structural Boundaries
The epidural space is a circumferential, potential anatomical space surrounding the dural sac, extending from the foramen magnum superiorly to the sacrococcygeal ligament (sacral hiatus) inferiorly. +-------------------------------------------------------------------------+
- | EPIDURAL SPACE BOUNDARIES & CONTENTS |
- +--------------------+----------------------------------------------------+
- | Anatomical Boundary| Anatomical Structure |
- +--------------------+----------------------------------------------------+
- | **Anterior** | Posterior Longitudinal Ligament & Vertebral Bodies |
- | **Posterior** | Ligamentum Flavum and Anterior Laminae |
- | **Lateral** | Pedicles and Intervertebral Foramina |
- | **Superior** | Foramen Magnum (Dura fuses to periosteum of cranium|
- | | preventing cranial spread of epidural local anesth)|
- | **Inferior** | Sacrococcygeal Ligament (Sacral Hiatus) |
- | **Contents** | Fat, lymphatics, segmental nerve roots, and the |
- | | **valveless Batson's internal vertebral venous px**|
+--------------------+----------------------------------------------------+ [EPIDURAL SPACE CROSS-SECTIONAL ARCHITECTURE]
- Anterior
- [Posterior Long. Ligament]
- |
- v
- [Epidural Space Fat]
- |
- v
- [Dura & Arachnoid Mater]
- |
- v
- [Spinal Cord / CSF Space]
- |
- v
- [Dura & Arachnoid Mater]
- |
- v
- [Epidural Space Fat]
- (Batson's Internal Venous Plexus)
- |
- v
- [LIGAMENTUM FLAVUM]
- |
- Posterior
- Batson's Internal Vertebral Venous Plexus
Structure: A network of thin-walled, valveless veins lying primarily in the anterolateral epidural space that communicates directly with the pelvic veins, azygos system, and intracranial venous sinuses.
Pathophysiology of Engorgement: Any clinical state that increases intra-abdominal pressure or compresses the inferior vena cava (e.g., pregnancy, morbid obesity, intra-abdominal tumors, ascites, coughing/Valsalva) forces blood into Batson's plexus.
Clinical Consequences:
Engorged veins compress and diminish the volume of the epidural space, requiring a 20 − 30 % 20 - 30\% 20 − 30% reduction in local anesthetic volume in term parturients to prevent excessively high block levels.
Greatly increases the risk of accidental epidural vein cannulation during catheter placement.
Skin-to-Epidural Space Distance
In ≈ 80 % \approx 80\% ≈ 80% of the adult population, the distance from the skin surface to the ligamentum flavum / epidural space is 4 − 6 cm 4 - 6 \text{ cm} 4 − 6 cm (average ≈ 5 cm \approx 5 \text{ cm} ≈ 5 cm ).
In thin patients, this distance may be < 3 cm <3 \text{ cm} < 3 cm ; in morbidly obese patients, it may exceed 8 − 10 cm 8 - 10 \text{ cm} 8 − 10 cm .
2. Loss-of-Resistance (LOR) Technique & Needle Selection +-------------------------------------------------------------------------+
- | EPIDURAL NEEDLE DESIGNS |
- +--------------------+----------------------------------------------------+
- | Needle Type | Distinguishing Characteristics |
- +--------------------+----------------------------------------------------+
- | **Tuohy Needle** | Curved Huber tip with 15° - 30° bevel deflection. |
- | (Most Common) | Pushes the dura away upon entry and directs the |
- | | catheter along the long axis of the epidural canal.|
- | **Hustead Needle** | Modified tip with intermediate (15°) bevel curve. |
- | **Crawford Needle**| Straight bevel needle without curve; higher risk of|
- | | dural puncture; preferred for steep thoracic angle.|
- +--------------------+----------------------------------------------------+
- Loss-of-Resistance: Air vs. Saline +-------------------------------------------------------------------------+
- | LOR TO AIR vs. LOR TO SALINE COMPARISON |
- +--------------------+------------------------+---------------------------+
- | Characteristic | LOR with Air | LOR with Saline |
- +--------------------+------------------------+---------------------------+
- | **Feel / Spring** | Compressible "spongy" | Non-compressible; smooth |
- | | bounce until breach | continuous tactile glide |
- | **Pneumocephalus | High risk if dura is | ZERO risk of |
- | Risk** | punctured (severe | pneumocephalus |
- | | acute headache) | |
- | **Block Quality** | Air bubbles can cause | Uniform distribution; |
- | | patchy, unblocked | lower incidence of |
- | | dermatomes | patchy blocks |
- | **Embolism Risk** | Venous air embolism | No air embolism risk |
- | | if vein is entered | |
- | **CSF Distinction**| Easy to differentiate | Must distinguish CSF from |
- | | gas from CSF fluid | injected warm saline |
- +--------------------+------------------------+---------------------------+
- Differentiating Cerebrospinal Fluid (CSF) from Saline
If fluid returns through the epidural needle or catheter:
Temperature: CSF is body temperature ( 37 ∘ C 37^\circ\text{C} 3 7 ∘ C / warm); saline injectate is room temperature (cool).
Glucose Test Strip: CSF contains glucose ( 45 − 80 mg/dL 45 - 80 \text{ mg/dL} 45 − 80 mg/dL ); saline contains 0 mg/dL 0 \text{ mg/dL} 0 mg/dL .
Protein Strip: CSF tests positive for protein; saline tests negative.
pH: CSF is slightly acidic/neutral (pH ≈ 7.32 \approx 7.32 ≈ 7.32 ).
Catheter Insertion Depth Rule
The epidural catheter should be threaded 3 − 5 cm 3 - 5 \text{ cm} 3 − 5 cm into the epidural space.
Depth Formula: Total Depth at Skin = Distance from Skin to LOR + ( 3 to 5 cm ) \text{Total Depth at Skin} = \text{Distance from Skin to LOR} + (3 \text{ to } 5 \text{ cm}) Total Depth at Skin = Distance from Skin to LOR + ( 3 to 5 cm ) .
Traps: Inserting < 3 cm <3 \text{ cm} < 3 cm increases the risk of premature dislodgement. Inserting > 5 cm >5 \text{ cm} > 5 cm increases the risk of catheter curling, unilateral transforaminal exit, knotting, or venous cannulation.
3. The Epidural Test Dose: Rationale, Pharmacology & Hemodynamics
Every epidural catheter must be formally tested prior to initiating a therapeutic infusion to rule out intravascular or subarachnoid (intrathecal) misplacement. +-------------------------------------------------------------------------+
- | STANDARD EPIDURAL TEST DOSE COMPOSITION |
- +-------------------------------------------------------------------------+
- | • **Volume:** 3.0 mL |
- | • **Local Anesthetic:** 1.5% Lidocaine = 45 mg Lidocaine |
- | • **Vasoconstrictor:** 1:200,000 Epinephrine = 5 mcg/mL = 15 mcg Epi |
+-------------------------------------------------------------------------+ +-------------------------------------------------------------------------+
- | TEST DOSE INTERPRETATION PROTOCOL |
- +-----------------------+-------------------------------------------------+
- | Malposition Tested | Positive Test Response Criteria |
- +-----------------------+-------------------------------------------------+
- | **Intravascular | • **Heart Rate increase ≥ 20 - 30 bpm** or |
- | Placement** | **Systolic Blood Pressure rise ≥ 15 mmHg** |
- | (Catheter in vein) | within **30 to 60 seconds** of injection |
- | | • Subjective symptoms: Metallic taste, auditory |
- | | tinnitus, circumoral numbness, palpitations |
- | **Subarachnoid | • Rapid development of **warmth, sensory loss, |
- | Placement** | and motor block in lower extremities** within |
- | (Catheter in CSF) | **2 to 3 minutes** (45 mg lidocaine spinal) |
- | **Correct Epidural | • Stable baseline vital signs without rapid T-wave|
- | Placement** | changes or profound spinal motor block |
- +-----------------------+-------------------------------------------------+
- Clinical Nuances in Special Patient Populations
Laboring Parturients: Uterine contractions can naturally increase heart rate by 15 − 20 bpm 15 - 20 \text{ bpm} 15 − 20 bpm . The test dose must be administered immediately between contractions . In obstetrics, a pulse pressure elevation > 15 % >15\% > 15% or ECG T-wave amplitude increase > 25 % >25\% > 25% provides sensitive confirmation of intravascular injection.
Beta-Blocked / Elderly Patients: Chronotropic response to epinephrine may be blunted. Look for an acute systolic blood pressure elevation ≥ 15 − 20 mmHg \ge 15 - 20 \text{ mmHg} ≥ 15 − 20 mmHg or pulse pressure widening rather than tachycardia.
NCE Golden Rule: A negative test dose does never grant absolute immunity against subsequent catheter migration. All subsequent therapeutic boluses must be fractionated ( 3 − 5 mL 3 - 5 \text{ mL} 3 − 5 mL aliquots every 3 − 5 minutes 3 - 5 \text{ minutes} 3 − 5 minutes ).
4. Combined Spinal-Epidural (CSE) Technique
Combined Spinal-Epidural (CSE) anesthesia unites the rapid, dense, predictable sensory block of spinal anesthesia with the flexibility and indwelling continuous analgesia of an epidural catheter. [NEEDLE-THROUGH-NEEDLE CSE TECHNIQUE]
1. Epidural Needle Identifies Space 2. Long Spinal Needle Passed to CSF
- [Tuohy 17G/18G] [Tuohy 17G/18G]
- || || [Spinal Needle 25-27G]
- || || ||
- v v ||
- === [Ligamentum Flavum] === === [Ligamentum Flavum] ===
- [Epidural Space] [Epidural Space]
- -- [Dura-Arachnoid] --- --- [Dura-Arachnoid] --- v (Dural puncture)
- [Subarachnoid Space] [Subarachnoid Space] ===> (CSF flow)
- Inject Spinal Dose
- Withdraw Spinal Needle
- Thread Epidural Catheter
- Clinical Advantages & Potential Pitfalls of CSE
Advantages: Immediate surgical analgesia (within 2 − 5 minutes 2 - 5 \text{ minutes} 2 − 5 minutes ); significantly lower total local anesthetic and opioid dose required compared to epidural alone; provides a reliable indwelling route for postoperative analgesia.
Pitfalls: Failure to obtain CSF through the long spinal needle; inability to verify epidural catheter functionality until the spinal block begins to regress; risk of epidural local anesthetic diffusing through the dural puncture hole (increasing spinal block height).
5. Post-Dural Puncture Headache (PDPH): Pathophysiology & Risk Profile
Post-Dural Puncture Headache (PDPH) is a classic iatrogenic complication resulting from a persistent breach in the dural-arachnoid membrane. [PDPH PATHOPHYSIOLOGIC CASCADE]
- Breach in Dura-Arachnoid Sheath (Accidental Wet Tap / Lumbar Puncture)
- |
- v
- Continuous Transdural CSF Leakage Exceeding Production (>0.35 mL/min)
- |
- v
- Intracranial Hypotension & Loss of CSF Cushion
- |
- +--------------------------+--------------------------+
- | |
- v v
- [Caudal "Brain Sag" in Upright Position] [Monro-Kellie Doctrine Compensation]
- Gravitational downward displacement • Loss of CSF volume triggers reflex
- Mechanical traction on meninges, anchoring cerebral venous and arterial
- dural veins, and tentorium cerebelli vasodilation
- **Traction on Cranial Nerves:** • Vascular component of throbbing
- **CN VI (Abducens):** Diplopia / Strabismus headache
- **CN VII & VIII:** Tinnitus, hearing loss, vertigo
- | |
- +--------------------------+--------------------------+
- |
- v
Bifrontal / Occipital Postural Headache (Worse Upright, Relieved Supine) +-------------------------------------------------------------------------+
- | CLINICAL RISK FACTORS FOR PDPH |
- +--------------------+----------------------------------------------------+
- | Risk Factor | High-Risk vs. Low-Risk Category |
- +--------------------+----------------------------------------------------+
- | **Patient Age** | Highest in **18 - 40 years** (pliable dura, active);|
- | | Lowest in prepubertal children and elderly (>65 yr)|
- | **Patient Sex** | **Females > Males (2:1)**; highest in pregnancy |
- | | (estrogen-mediated dural elasticity, pushing) |
- | **Needle Design** | **Cutting (Quincke) >> Non-cutting Pencil-Point** |
- | | (Whitacre / Sprotte reduce risk by >75-80%) |
- | **Needle Gauge** | Large (17-18G Tuohy: 70-80% risk after wet tap) >> |
- | | Small (25-27G pencil-point: <1% risk) |
- | **Bevel Direction**| Perpendicular transects fibers; **parallel to |
- | | longitudinal fibers** separates them (lower risk) |
- +--------------------+----------------------------------------------------+
- Clinical Presentation
Hallmark Feature: Severe, throbbing postural headache (frontal, occipital, or band-like radiating to the neck and shoulders) that worsens dramatically within 15-30 seconds of sitting or standing and is substantially or completely relieved by lying flat (supine) .
Onset: Typically develops within 12 − 48 hours 12 - 48 \text{ hours} 12 − 48 hours post-procedure (rarely immediate, rarely > 5 days >5 \text{ days} > 5 days ).
6. PDPH Management: Conservative Protocols vs. Epidural Blood Patch (EBP) +-------------------------------------------------------------------------+
- | CONSERVATIVE vs. DEFINITIVE PDPH THERAPY |
- +--------------------+------------------------+---------------------------+
- | Modality | Therapeutic Regimen | Mechanism of Action |
- +--------------------+------------------------+---------------------------+
- | **Conservative | • Horizontal bed rest | • Minimizes gravitational |
- | Measures** | • Aggressive IV / oral | downward brain traction |
- | | hydration | • Restores baseline CSF |
- | | • Oral / IV Caffeine | • Caffeine (adenosine rec.|
- | | (300-500 mg IV) | antagonist) causes |
- | | • NSAIDs & Acetaminophen| cerebral vasoconstriction|
- | | • Cosyntropin (ACTH) | • ACTH stimulates adrenal |
- | | (1 mg IV/IM) | mineralocorticoid & CSF |
- | **Sphenopalatine | Transnasal 2-4% | Blocks parasympathetic- |
- | Ganglion Block** | Lidocaine swabs | mediated cerebral vasodila|
- | **Epidural Blood | **15 - 20 mL sterile | • Gelatinous clot seals |
- | Patch (EBP)** | autologous blood** | dural hole immediately |
- | (Definitive) | injected at/below level| • Transmits pressure wave |
- | | of original puncture | to restore CSF dynamics |
+--------------------+------------------------+---------------------------+ [EPIDURAL BLOOD PATCH (EBP) EXECUTION PROTOCOL]
- Step 1: Sterile Setup Step 2: Dual Operator Access
- +-----------------------+ +----------------------------------------+
- | • Informed consent | | • Operator 1: Aseptic LOR into epidural|
- | • Verify absence of | | space at or one space BELOW wet tap |
- | contraindications | | • Operator 2: Sterile venipuncture of |
- | (coagulopathy, | | 20 mL autologous blood |
- | sepsis, local skin | +----------------------------------------+
- | infection) | |
- +-----------------------+ v
- Step 3: Slow Blood Injection
- +----------------------------------------+
- | • Inject 15 - 20 mL blood slowly |
- | • Halt immediately if severe back pain |
- | or lower extremity radiculopathy |
- +----------------------------------------+
- |
- v
- Step 4: Post-Procedure Care
- +----------------------------------------+
- | • Maintain supine position for 1-2 hrs |
- | • 85-90% immediate relief; repeat patch|
- | in 24-48 hrs if symptoms recur (95%) |
- +----------------------------------------+